Sabra, L

Development and validation of an ELISA for the quantification of anti-ALK autoantibodies in ALCL Patients

Salhotra, S

Riboflavin metabolism as a selective therapeutic vulnerability in Acute Myeloid Leukemia (AML)

Samaddar, R

Elucidating the role of Exportin-1 (XPO1) in NPM1c-driven acute myeloid leukemogenesis

Santosa Hidajat, J

Targeting the fetal transcriptional landscape of pediatric AML

Schaal, K

Epigenetic remodeling via HDAC6 inhibition amplifies T cell responses in pediatric myeloid lineage leukemia

Schad, P S

Spatial and temporal tumor heterogeneity representation in liquid biopsies of pediatric precision oncology patients

Schattling, B

Optimizing Antibody Production for Neuroblastoma Using a Hollow-Fiber Bioreactor

Glycosylation and Immune Evasion in Neuroblastoma

Schätz, C

Mechanism and vulnerabilities of the SAGA complex in leukemia

Scheuermann, S

Minimal Invasive Detection of Circulating Biomarkers in Pediatric Cancer Patients Undergoing Chimeric Antigen Receptor

Schewe, D M

CD127-directed immunotherapy outperforms Imatinib in preclinical ABL-class fusion+ BCP-ALL via a dual mode of action

A quiescence/TGF-β1 CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML

Schliehe-Diecks, J

Targeting the HSP90-CDK9-Axis Sensitizes Pediatric AML (pAML) cells to Venetoclax

Epigenetic remodeling via HDAC6 inhibition amplifies T cell responses in pediatric myeloid lineage leukemia

Schliemann, C

Rapid Epigenomic Classification of Acute Leukemia

Schlueter, J

Multi-functional potency assay for CAR-NK cells: Mapping cytotoxicity, degranulation and proliferation in one

Schmell, A L

Preemptive targeting of preleukemic cells with pathway-directed therapies: a novel approach to prevent myeloid leukemia

Targeting the fetal transcriptional landscape of pediatric AML

Schmid, J P

CCND3 Knockout Impairs Leukemia Growth in PDX AML Models Revealing a New Therapeutic Vulnerability

Schmidt, A

Clinical evaluation of ex vivo drug sensitivity profiling in the pediatric precision oncology program INFORM

Schneider, B

miRNA signatures in Burkitt leukemia and lymphoma in children and young adults

Schneider, C

Riboflavin metabolism as a selective therapeutic vulnerability in Acute Myeloid Leukemia (AML)

Schnell, J

Mechanisms of cell death induced by NK cells in DLBCL

Schoof, M

Molecular and histological analyses of AT/RT-TYR suggest the choroid plexus of the fourth ventricle as cellular origin

Exploring the local tumor infiltration of medulloblastoma into the adjacent brain tissue

Extrachromosomal DNA as a potential therapy target in a pediatric high-grade glioma mouse model with MYCN amplification

Schreuders, E

Deciphering impact of B-cell precursor acute lymphoblastic leukemia bone marrow microenvironment on immune cell function

Schroeder, M

A quiescence/TGF-β1 CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML

Schüler, L

Targeting novel chromatin vulnerabilities in childhood acute myeloid leukemia

Schüller, U

Inter- and intratumoral heterogeneity in MYCN-amplified spinal ependymoma.

Molecular and histological analyses of AT/RT-TYR suggest the choroid plexus of the fourth ventricle as cellular origin

Exploring the local tumor infiltration of medulloblastoma into the adjacent brain tissue

ctDNA from preoperatively collected CSF predicts molecular classification of brain tumors

Extrachromosomal DNA as a potential therapy target in a pediatric high-grade glioma mouse model with MYCN amplification

Enhancing Nanopore cfDNA diagnostics of pediatric brain tumors with machine learning

Schultze-Seemann, F

Understanding the role of linear ubiquitination in lysophagy and lysosome-mediated cell death in acute myeloid leukemia

Schuschel, K

Targeting novel chromatin vulnerabilities in childhood acute myeloid leukemia

CRISPR-Cas-Based Optimization of (CAR-)NK Cell Therapy in Pediatric AML

Patient-Derived Xenograft Models in Leukemia Research: Advancing Preclinical Studies

Relapse Mechanisms in Children with Down Syndrome and Myeloid Leukemia

Unveiling the Molecular Complexity of AML through Advanced Multi-Omics Analysis

Preemptive targeting of preleukemic cells with pathway-directed therapies: a novel approach to prevent myeloid leukemia

CRISPR-based optimization of CAR NK cell therapy for pediatric AML

High-throughput drug screening of triple combinations in pediatric acute myeloid leukemia

Deciphering the interplay between DNA methylation and CTCF in AML

Analyzing Transcriptomic Alternative Landscapes in Pediatric AML: Insights from Long-Read RNA Sequencing

Analysis of novel transcripts and alternative isoform usage in acute myeloid leukemia

Schuster, S

CRISPR-based optimization of CAR NK cell therapy for pediatric AML

Memory-like NK cell and CD19-antibody based immunotherapy combined with TKI has antitumor effects against Ph(-like) ALL

Schütze, K

Production of Universal CAR-T cells against the αβ-TCR with All-in-one Nanoblades

Schwarz, N

Minimal Invasive Detection of Circulating Biomarkers in Pediatric Cancer Patients Undergoing Chimeric Antigen Receptor

Schwarzer, A

Exploring the translational potential of EZH2-controlled fetal gene signature in AML

Seitz, C

Minimal Invasive Detection of Circulating Biomarkers in Pediatric Cancer Patients Undergoing Chimeric Antigen Receptor

Semeth, A

Digenic Heterozygous Variants in FANCF and FANCM Disrupt the Fanconi Anemia Pathway in Childhood Leukemia

Understanding the influence of JAK3 germline vs. somatic variants

Seruggia, D

Deciphering the role of non-coding sequence variants predisposing to pediatric B-ALL

Mechanism and vulnerabilities of the SAGA complex in leukemia

Functional identification and targeting of zinc-finger containing proteins at domain resolution in leukemia

Seyboldt, H

Investigating Senescence-Induced Tumor Plasticity in High Risk Neuroblastoma

Shepheard, W

Development and validation of an ELISA for the quantification of anti-ALK autoantibodies in ALCL Patients

Shokraie, F

TMZ Sensitization in GBM Cell Lines by Sequential Fadraciclib Treatment: An MGMT-Independent Strategy

Simon, N

Minimal Invasive Detection of Circulating Biomarkers in Pediatric Cancer Patients Undergoing Chimeric Antigen Receptor

Smeets, MW E

Deciphering impact of B-cell precursor acute lymphoblastic leukemia bone marrow microenvironment on immune cell function

Beneficial impact of bone marrow supportive tissues on acute lymphoblastic leukemia

Smyrilli, K

Development of a ROS- and lysosome-addressing combination treatment for relapsed Neuroblastoma

Sönksen, M

ctDNA from preoperatively collected CSF predicts molecular classification of brain tumors

Spohn, M

Glycosylation and Immune Evasion in Neuroblastoma

Stachura, P

Epigenetic remodeling via HDAC6 inhibition amplifies T cell responses in pediatric myeloid lineage leukemia

Stampa, G

Investigating the role of GSK3β inhibition by Elraglusib in pediatric acute myeloid leukemia

Stegmaier, K

Riboflavin metabolism as a selective therapeutic vulnerability in Acute Myeloid Leukemia (AML)

Steinicke, T L

Rapid Epigenomic Classification of Acute Leukemia

Stoltze, U K

Identification of germline PAX5 variants in pediatric B-ALL: Establishing murine and hiPSC model systems for profiling

Strauss, J

Memory-like NK cell and CD19-antibody based immunotherapy combined with TKI has antitumor effects against Ph(-like) ALL